Researchers evaluated the impact of upadacitinib on early pain control among patients with axial spondyloarthritis.

The approval was supported by data from 3 double-blind, placebo-controlled trials that included a total of 1474 patients who met the 2016 ACR criteria for diagnosis of fibromyalgia.

Researchers assessed how obesity influences spinal radiographic features among patients with metabolic syndrome.

The researchers found that students with autism reported significantly higher rates of anxiety (64.5%) and depression (48.2%) versus peers without autism (9.4% and 7.6%, respectively). Compared with ...

Researchers assessed movement behaviors among adolescents with hypermobility spectrum disorder or hypermobile Ehlers-Danlos syndrome.

Cassandra Pingali, MPH, from the CDC in Atlanta, and colleagues analyzed data from the 2024 National Immunization Survey-Teen to examine national, state, and selected local area vaccination coverage ...

More than 20% of ischemic strokes in patients aged 45 years or younger are associated with Antiphospholipid syndrome, and its exact etiology and pathophysiology are not yet fully understood.

Signs and symptoms linked with withdrawal are relatively consistent in the pediatric population; they can be seen after 5 or more days of opioids.

Researchers conducted a latent profile analysis examining personality characteristics of older suicide attempters.

The approval was based on Part 1 (72 week data) of the randomized, double-blind, placebo-controlled phase 3 ESSENCE trial.

HealthDay News — The US Food and Drug Administration (FDA) has approved the ketamine product, KETARx, for use in surgical pain management. Ketamine is the only psychedelic or psychedelic-adjacent drug ...

Ianalumab is a fully human monoclonal antibody designed to deplete B cells via antibody-dependent cellular toxicity and inhibit BAFF-R-mediated signals of B cell function and survival.